Relmada Therapeutics Inc

NASDAQ:RLMD   2:39:35 PM EDT
18.97
-0.24 (-1.25%)
Earnings Announcements

Relmada Therapeutics Reports Fourth Quarter Results

Published: 03/23/2022 20:29 GMT
Relmada Therapeutics Inc (RLMD) - Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-year 2021 Financial Results.
Q4 Loss per Share $1.80.
Q4 Earnings per Share View $-1.83 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.27

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.27

More details on our Analysts Page.